Surprisingly, we found that immunoproteasomes are responsible for the bulk of activity recovered in ONX-treated cells expressing the MLL–AF4 fusion protein and in T-ALL cells. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.